Screening and Biosensor-Based Approaches for Lung Cancer Detection
暂无分享,去创建一个
[1] Khairul Hamimah Abas,et al. Magnetic induction tomography: A brief review , 2015 .
[2] Jim M. Wild,et al. Lung imaging in cystic fibrosis , 2009 .
[3] Wang Bi. A three-channel high-precision optical detecting system for lung cancer marker CYFRA21-1 , 2013 .
[4] Feng Liu,et al. Expression and clinicopathological significance of S100 calcium binding protein A2 in lung cancer patients of Chinese Han ethnicity. , 2017, Clinica chimica acta; international journal of clinical chemistry.
[5] Shaoyi Jiang,et al. irect detection of carcinoembryonic antigen autoantibodies in clinical human erum samples using a surface plasmon resonance sensor on Ladda , 2009 .
[6] Marek Piliarik,et al. Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging , 2009, Analytical and bioanalytical chemistry.
[7] Farrokh Karimi,et al. Graphene oxide based nano-biosensor for the detection of deletion mutation in exon 19 of EGFR gene, leading to lung cancer , 2016 .
[8] Yildiz Uludag,et al. Cancer biomarker detection in serum samples using surface plasmon resonance and quartz crystal microbalance sensors with nanoparticle signal amplification. , 2012, Analytical chemistry.
[9] Shusheng Zhang,et al. Ultrasensitive Detection of DNA and Ramos Cell Using In Situ Selective Crystallization Based Quartz Crystal Microbalance. , 2017, Analytical chemistry.
[10] Frank D Gilliland,et al. Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. , 2004, Carcinogenesis.
[11] Young Min Han,et al. Comparison of Survival Rate in Primary Non-Small-Cell Lung Cancer Among Elderly Patients Treated With Radiofrequency Ablation, Surgery, or Chemotherapy , 2012, CardioVascular and Interventional Radiology.
[12] E Chyczewska,et al. K-ras codon 12 mutations may be detected in serum of patients suffering from adeno- and large cell lung carcinoma. A preliminary report. , 2001, Folia histochemica et cytobiologica.
[13] Anthony J. Peyton,et al. Performance of a FPGA-based Direct Digitising Signal Measurement module for MIT , 2010 .
[14] G Parraga,et al. TH-CD-202-09: Free-Breathing Proton MRI Functional Lung Avoidance Maps to Guide Radiation Therapy. , 2016, Medical physics.
[15] A. N. Matlachov,et al. Thin-Film Planar Gradiometer with Long Baseline , 2006 .
[16] O. Dössel,et al. Planar system for magnetic induction conductivity measurement using a sensor matrix. , 2004, Physiological measurement.
[17] Yasar Gurbuz,et al. Surface plasmon resonance based immunosensor for the detection of the cancer biomarker carcinoembryonic antigen. , 2011, Talanta.
[18] W. Szeszkowski,et al. Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times , 2012, European Radiology.
[19] Luca Marmugi,et al. Optical Magnetic Induction Tomography of the Heart , 2016, Scientific Reports.
[20] Lulu Wang,et al. Imaging of Lung Structure Using Holographic Electromagnetic Induction , 2017, IEEE Access.
[21] Zeynep Altintas,et al. Biomarkers and biosensors for the early diagnosis of lung cancer , 2013 .
[22] J. Austin,et al. Detection of lung cancer using weighted digital analysis of breath biomarkers. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[23] Paul V Carlile. Lung cancer screening: where have we been? Where are we going? , 2015, The Journal of the Oklahoma State Medical Association.
[24] Min Han,et al. Comparison with reconstruction algorithms in magnetic induction tomography , 2016, Physiological measurement.
[25] G. Cooper,et al. Cellular transforming genes. , 1982, Science.
[26] P. Di Barba,et al. Optimization of the MIT Field Exciter by a Multiobjective Design , 2009, IEEE Transactions on Magnetics.
[27] Hui Li,et al. CD59 is overexpressed in human lung cancer and regulates apoptosis of human lung cancer cells. , 2013, International journal of oncology.
[28] R. Miceli,et al. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. , 1999, Anticancer research.
[29] Masahiro Endo,et al. Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study , 2013, BMC Cancer.
[30] Yang Zhao,et al. Association between MicroRNA Polymorphisms, Expressions, Lung Cancer Development and Prognosis , 2009 .
[31] Min Han,et al. Magnetic Induction Tomography , 2015 .
[32] Toshio Itoh,et al. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns , 2016, Sensors.
[33] Naveed Hasan,et al. Lung Cancer Screening Beyond Low-Dose Computed Tomography: The Role of Novel Biomarkers , 2014, Lung.
[34] Kathleen Brown,et al. Lung cancer screening with CT. , 2008, Clinics in chest medicine.
[35] R L Wahl,et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. , 1999, Radiology.
[36] J. Austin,et al. Prediction of lung cancer using volatile biomarkers in breath. , 2007, Cancer biomarkers : section A of Disease markers.
[37] S. Nicolaou,et al. Traumatic pneumothorax detection with thoracic US: correlation with chest radiography and CT--initial experience. , 2002, Radiology.
[38] Waseem Asghar,et al. Electrical detection of cancer biomarker using aptamers with nanogap break-junctions , 2012, Nanotechnology.
[39] C. Pöttgen,et al. Surgery after multimodality treatment for non-small-cell lung cancer. , 2004, Lung cancer.
[40] I. Behrmann,et al. MiRNA-29: a microRNA family with tumor-suppressing and immune-modulating properties. , 2013, Current molecular medicine.
[41] E. Martinelli,et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. , 2003, Biosensors & bioelectronics.
[42] Tetsuya Osaka,et al. Label-free detection of tumor markers using field effect transistor (FET)-based biosensors for lung cancer diagnosis , 2015 .
[43] Ning Xia,et al. Simultaneous and label-free determination of wild-type and mutant p53 at a single surface plasmon resonance chip preimmobilized with consensus DNA and monoclonal antibody. , 2009, Analytical chemistry.
[44] Yoon Hwan Chang,et al. Comparison of the serum fibrin-fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer. , 2014, Biomedical reports.
[45] Bjørn Winther,et al. Determination of the small cell lung cancer associated biomarker pro-gastrin-releasing peptide (ProGRP) using LC-MS. , 2007, Journal of separation science.
[46] Anthony J. Peyton,et al. Imaging molten steel flow profiles , 2001 .
[47] K. Lewis,et al. A review of novel biological tools used in screening for the early detection of lung cancer , 2009, Postgraduate Medical Journal.
[48] H Scharfetter,et al. Hardware for quasi-single-shot multifrequency magnetic induction tomography (MIT): the Graz Mk2 system. , 2008, Physiological measurement.
[49] J. Howington,et al. Survival after resection for lung cancer is the outcome that matters. , 2004, American journal of surgery.
[50] M. Baiget,et al. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer , 2017, Clinical and Translational Oncology.
[51] Wei Chen,et al. Detection EGFR exon 19 status of lung cancer patients by DNA electrochemical biosensor. , 2016, Biosensors & bioelectronics.
[52] N. H. Saunders,et al. A feasibility study of in vivo electromagnetic imaging. , 1993, Physics in medicine and biology.
[53] J. Pyun,et al. Additive assay of cancer marker CA 19-9 by SPR biosensor , 2006 .
[54] Ulrike Tisch,et al. Classification of lung cancer histology by gold nanoparticle sensors. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[55] A. Weber,et al. Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos , 2011, Archives of Toxicology.
[56] L M Lechuga,et al. Label-free detection of DNA mutations by SPR: application to the early detection of inherited breast cancer , 2009, Analytical and bioanalytical chemistry.
[57] N J Heyer,et al. Lung cancer in chromate-exposed aerospace workers. , 1996, Journal of occupational and environmental medicine.
[58] Geoffrey G. Zhang,et al. Impact of dose on lung ventilation change calculated from 4D-CT using deformable image registration in lung cancer patients treated with SBRT , 2015, Journal of Radiation Oncology.
[59] Marek Piliarik,et al. Surface plasmon resonance biosensor for parallelized detection of protein biomarkers in diluted blood plasma. , 2010, Biosensors & bioelectronics.
[60] Mei Yang,et al. A highly sensitive electrochemical DNA biosensor for rapid detection of CYFRA21-1, a marker of non-small cell lung cancer , 2015 .
[61] M. S. Beck,et al. Electromagnetic inductance tomography (EMT): sensor, electronics and image reconstruction algorithm for a system with a rotatable parallel excitation field , 1998 .
[62] Ying Liu,et al. MiR‐449c targets c‐Myc and inhibits NSCLC cell progression , 2013, FEBS letters.
[63] G. Pfeifer,et al. Second-hand smoke and human lung cancer. , 2008, The Lancet. Oncology.
[64] Tarek Mekhail,et al. Exhaled Breath Analysis with a Colorimetric Sensor Array for the Identification and Characterization of Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[65] Ailin Liu,et al. Simple and effective label-free electrochemical immunoassay for carbohydrate antigen 19-9 based on polythionine-Au composites as enhanced sensing signals for detecting different clinical samples , 2017, International journal of nanomedicine.
[66] Robert T. Eagan,et al. Combination chemotherapy and radiation therapy in small cell carcinoma of the lung , 1973, Cancer.
[67] Chien Chou,et al. Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor. , 2010, Analytical chemistry.
[68] Weiling Fu,et al. A SPR biosensor based on signal amplification using antibody-QD conjugates for quantitative determination of multiple tumor markers , 2016, Scientific reports.
[69] Kevin M. Johnson,et al. Detection of Small Pulmonary Nodules with Ultrashort Echo Time Sequences in Oncology Patients by Using a PET/MR System. , 2016, Radiology.
[70] Antoine Flahault,et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). , 2007, Lung cancer.
[71] P. Mazzone,et al. Detection of lung cancer by sensor array analyses of exhaled breath. , 2005, American journal of respiratory and critical care medicine.
[72] Nevzat Karabulut,et al. Comparison of low-dose and standard-dose helical CT in the evaluation of pulmonary nodules , 2002, European Radiology.
[73] Matthias Reimold,et al. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[74] Chong-Jen Yu,et al. GM2-Activator Protein: A New Biomarker for Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[75] Douglas K Owens,et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. , 2003, Annals of internal medicine.
[76] Huijuan Jiang,et al. Tumor M2 pyruvate kinase in diagnosis of nonsmall cell lung cancer: A meta-analysis based on Chinese population. , 2015, Journal of cancer research and therapeutics.
[77] F Levi,et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[78] Jin-Wei Jia,et al. Clinical significance of annexin II expression in human non-small cell lung cancer , 2013, Tumor Biology.
[79] Célia Lourenço,et al. Breath Analysis in Disease Diagnosis: Methodological Considerations and Applications , 2014, Metabolites.
[80] Jens Haueisen,et al. Sensitivity Comparisons of Cylindrical and Hemi-Spherical Coil Setups for Magnetic Induction Tomography , 2009 .
[81] Ignacio I Wistuba,et al. Lung Cancer Biomarkers. , 2017, Hematology/oncology clinics of North America.
[82] G. Tricoles,et al. Microwave holography: Applications and techniques , 1977, Proceedings of the IEEE.
[83] Hermann Scharfetter,et al. Planar gradiometer for magnetic induction tomography (MIT): theoretical and experimental sensitivity maps for a low-contrast phantom. , 2004, Physiological measurement.
[84] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[85] Martín Mateo Mc,et al. Serum copper, ceruloplasmin, lactic-dehydrogenase and alpha 2-globulin in lung cancer. , 1979 .
[86] Wentao Yue,et al. Label-free detection of p53 antibody using a microcantilever biosensor with piezoresistive readout , 2009, 2009 IEEE Sensors.
[87] Yannick Crémillieux,et al. Validation of simple and robust protocols for high‐resolution lung proton MRI in mice , 2010, Magnetic resonance in medicine.
[88] Woon-Puay Koh,et al. CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study , 2017, Carcinogenesis.
[89] Takashi Isobe,et al. Expression of α and β genes of human chorionic gonadotropin in lung cancer , 1997 .
[90] Kevin Gleeson,et al. Detection of lung cancer with volatile markers in the breath. , 2003, Chest.
[91] Manuchehr Soleimani,et al. Experimental evaluation of conductive flow imaging using magnetic induction tomography , 2015 .
[92] Weiling Song,et al. Ultrasensitive detection of nucleic acids and proteins using quartz crystal microbalance and surface plasmon resonance sensors based on target-triggering multiple signal amplification strategy. , 2017, Analytica chimica acta.
[93] Bin He,et al. Magnetoacoustic imaging of human liver tumor with magnetic induction. , 2011, Applied physics letters.
[94] D. Naidich,et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.
[95] N. Peled,et al. Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects , 2017, Lung Cancer.
[96] Hermann Scharfetter,et al. Optimum Receiver Array Design for Magnetic Induction Tomography , 2009, IEEE Transactions on Biomedical Engineering.
[97] R. Stephens,et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.
[98] Vicky Goh,et al. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[99] Yanjun Dong,et al. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer. , 2016, Journal of cancer research and therapeutics.
[100] E. Mark,et al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. , 2001, Cancer research.
[101] D. Aberle,et al. Results of initial low-dose computed tomographic screening for lung cancer. , 2013, The New England journal of medicine.
[102] A. Żywica,et al. Magnetoacoustic tomography with magnetic induction for biological tissue imaging: numerical modelling and simulations , 2016 .
[103] Johan Alexander Huisman,et al. Three‐dimensional imaging of subsurface structural patterns using quantitative large‐scale multiconfiguration electromagnetic induction data , 2014 .
[104] C. Zettler,et al. p53 and Bcl-2 protein expression and its relationship with prognosis in small-cell lung cancer. , 2003, Clinical lung cancer.
[105] Xu Qingle. The application significance of serum CYFRA21-1 change in therapeutic efficacy monitoring of advanced stage NSCLC , 2013 .
[106] L Räf,et al. [Early diagnosis of breast cancer]. , 1979, Lakartidningen.
[107] David Binns,et al. The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[108] Koichi Abe,et al. Electrochemical Detection of Vascular Endothelial Growth Factor with Aptamer Sandwich , 2012 .
[109] M. Ruiz-Argüello,et al. A New Biomarker Panel in Bronchoalveolar Lavage for an Improved Lung Cancer Diagnosis , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[110] S. Dacic,et al. Molecular Prognostic Markers of Lung Cancer , 2012 .
[111] H Scharfetter,et al. Sensitivity maps and system requirements for magnetic induction tomography using a planar gradiometer. , 2001, Physiological measurement.
[112] Mustafa Kemal Sezgintürk,et al. A new impedimetric biosensor utilizing VEGF receptor-1 (Flt-1): early diagnosis of vascular endothelial growth factor in breast cancer. , 2011, Biosensors & bioelectronics.
[113] R. Cataneo,et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.
[114] W P Bennett,et al. Molecular epidemiology of human cancer risk: gene–environment interactions and p53 mutation spectrum in human lung cancer , 1999, The Journal of pathology.
[115] D Gürsoy,et al. Tracking of object movements for artefact suppression in Magnetic Induction Tomography (MIT) , 2010 .
[116] Kazuo Sato,et al. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm , 2017, Sensors.
[117] Shekhar Bhansali,et al. Lung cancer and its early detection using biomarker-based biosensors. , 2011, Chemical reviews.
[118] Yoshiharu Ohno,et al. Ultra‐short echo time (UTE) MR imaging of the lung: Comparison between normal and emphysematous lungs in mutant mice , 2010, Journal of magnetic resonance imaging : JMRI.
[119] N Taniguchi,et al. Enzyme-linked immunosorbent assay for human manganese-containing superoxide dismutase and its content in lung cancer. , 1984, Journal of the National Cancer Institute.
[120] R. W. Lau,et al. The dielectric properties of biological tissues: III. Parametric models for the dielectric spectrum of tissues. , 1996, Physics in medicine and biology.
[121] Omowunmi A Sadik,et al. Immunosensors for quantifying cyclooxygenase 2 pain biomarkers. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[122] J. Biederer,et al. Analysis of artefacts and detail resolution of lung MRI with breath-hold T1-weighted gradient-echo and T2-weighted fast spin-echo sequences with respiratory triggering , 2002, European Radiology.
[123] Ming-Shyan Huang,et al. Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan , 2008, BMC Cancer.
[124] H. Brisse,et al. Comment on: Are the studies on cancer risk from CT scans biased by indication? Elements of answer from a large-scale cohort study in France , 2015, British Journal of Cancer.
[125] Luke P. Lee,et al. Single-step nanoplasmonic VEGF165 aptasensor for early cancer diagnosis. , 2012, ACS nano.
[126] Jiro Ishida,et al. A case of primary lung cancer lesion demonstrated by F-18 FDG positron emission tomography/computed tomography (PET/CT) one year after the detection of metastatic brain tumor. , 2011, Oncology letters.
[127] Irina Kusmartseva,et al. Panel of serum biomarkers for the diagnosis of lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[128] Joshua Dajac,et al. To Screen or not to Screen: Low Dose Computed Tomography in Comparison to Chest Radiography or Usual Care in Reducing Morbidity and Mortality from Lung Cancer , 2016, Cureus.
[129] O Dössel,et al. Design and performance of a planar-array MIT system with normal sensor alignment. , 2005, Physiological measurement.
[130] Lixing Weng,et al. Early Lung Cancer Diagnosis by Biosensors , 2013, International journal of molecular sciences.
[131] Ugo Pastorino,et al. Computed tomography screening and lung cancer outcomes. , 2007, JAMA.
[132] J. Downward. Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.
[133] Subhashini Yaturu,et al. Metastases to the Thyroid Presenting as a Metabolically Inactive Incidental Thyroid Nodule with Stable Size in 15 Months , 2014, Case reports in endocrinology.
[134] R. W. Lau,et al. The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz. , 1996, Physics in medicine and biology.
[135] S. Tumański. Induction coil sensors—a review , 2007 .
[136] John K. Wiencke,et al. p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer , 2001 .
[137] Yang Zhou,et al. Neuron-specific enolase, histopathological types, and age as risk factors for bone metastases in lung cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[138] Xiaoying Wang,et al. Sensitive detection of p53 tumor suppressor gene using an enzyme-based solid-state electrochemiluminescence sensing platform. , 2011, Biosensors & bioelectronics.
[139] Thomas Beyer,et al. PET/CT is a cost-effective tool against cancer: synergy supersedes singularity , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[140] Li-Li Zhu,et al. CYFRA21-1 as a serum tumor marker for follow-up patients with squamous cell lung carcinoma and oropharynx squamous cell carcinoma. , 2013, Biomarkers in medicine.
[141] Byung-Tae Kim,et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. , 2005, Radiology.
[142] P. Efron,et al. Effects of trauma , hemorrhagic shock , and chronic stress on lung VEGF , 2017 .
[143] Davide Ippolito,et al. Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[144] H Griffiths,et al. Magnetic induction tomography: phase versus vector-voltmeter measurement techniques , 2003, Physiological measurement.
[145] Tarek Mekhail,et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array , 2007, Thorax.
[146] W. Boireau,et al. Surface plasmon resonance imaging in arrays coupled with mass spectrometry (SUPRA–MS): proof of concept of on-chip characterization of a potential breast cancer marker in human plasma , 2012, Analytical and Bioanalytical Chemistry.
[147] Qing Lan,et al. Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. , 2009, Lung cancer.
[148] Xianting Ding,et al. Electrochemical detection of lung cancer specific microRNAs using 3D DNA origami nanostructures. , 2015, Biosensors & bioelectronics.
[149] Mojtaba Shamsipur,et al. A high sensitive electrochemical aptasensor for the determination of VEGF(165) in serum of lung cancer patient. , 2015, Biosensors & bioelectronics.
[150] H Griffiths,et al. A highly phase-stable differential detector amplifier for magnetic induction tomography. , 2011, Physiological measurement.
[151] H. Lackner,et al. Magnetic induction tomography: hardware for multi-frequency measurements in biological tissues. , 2001, Physiological measurement.
[152] M C Martin Mateo,et al. Serum copper, ceruloplasmin, lactic-dehydrogenase and alpha 2-globulin in lung cancer. , 1979, Biomedicine / [publiee pour l'A.A.I.C.I.G.].
[153] A. A. Modestov,et al. Electrochemical aptasensor for lung cancer-related protein detection in crude blood plasma samples , 2016, Scientific Reports.
[154] Manuchehr Soleimani,et al. Theoretical and Experimental Evaluation of Rotational Magnetic Induction Tomography , 2012, IEEE Transactions on Instrumentation and Measurement.
[155] Hans-Ulrich Kauczor,et al. Lung MRI at 1.5 and 3 Tesla: Observer Preference Study and Lesion Contrast Using Five Different Pulse Sequences , 2007, Investigative radiology.
[156] V Kalff,et al. F‐18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma , 2001, Cancer.
[157] Kazuya Kondo,et al. The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer. , 2005, Lung cancer.
[158] W. Hsu,et al. Role of preoperative PET‐CT in assessing mediastinal and hilar lymph node status in early stage lung cancer , 2012, Journal of the Chinese Medical Association : JCMA.
[159] Patricia Brunner,et al. Solution of the inverse problem of magnetic induction tomography (MIT) , 2005, Physiological measurement.
[160] H. Haick,et al. Sensors for breath testing: from nanomaterials to comprehensive disease detection. , 2014, Accounts of chemical research.
[161] A. Dirksen,et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT , 2012, Thorax.
[162] P. Thompson,et al. Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer , 2008, Biological chemistry.
[163] P. Mazzone,et al. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[164] N. Thacker,et al. Quantifying heterogeneity in human tumours using MRI and PET. , 2012, European journal of cancer.
[165] Hermann Scharfetter,et al. A new type of gradiometer for the receiving circuit of magnetic induction tomography (MIT). , 2005, Physiological measurement.
[166] Guangshun Wang,et al. Serum cyfra21-1 as a biomarker in patients with nonsmall cell lung cancer. , 2014, Journal of cancer research and therapeutics.
[167] Nevzat G. Gencer,et al. Electrical conductivity imaging via contactless measurements: an experimental study , 2003, IEEE Transactions on Medical Imaging.
[168] Raffaele Velotta,et al. Effective antibodies immobilization and functionalized nanoparticles in a quartz-crystal microbalance-based immunosensor for the detection of parathion , 2017, PloS one.
[169] A. Stromberg,et al. Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[170] Xuguo Sun,et al. Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection. , 2014, Biomedical reports.
[171] S. Stuckey,et al. Proton Density MRI Increases Detection of Cervical Spinal Cord Multiple Sclerosis Lesions Compared with T2-Weighted Fast Spin-Echo , 2016, American Journal of Neuroradiology.
[172] John Clarke,et al. Superconducting thin‐film gradiometer , 1978 .
[173] C H Igney,et al. A measurement system and image reconstruction in magnetic induction tomography. , 2008, Physiological measurement.
[174] Valentina Donzella,et al. Optical biosensors to analyze novel biomarkers in oncology , 2011, Journal of biophotonics.
[175] Rong Liu,et al. Alteration of serum miR-206 and miR-133b is associated with lung carcinogenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 2013, Toxicology and applied pharmacology.
[176] R. Stolz,et al. LTS SQUID sensor with a new configuration , 1999 .
[177] Suyan Tian,et al. Identification of differentially-expressed genes between early-stage adenocarcinoma and squamous cell carcinoma lung cancer using meta-analysis methods. , 2017, Oncology letters.
[178] C. Pérez,et al. PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings. , 2017, Radiologia.
[179] Ian O. Ellis,et al. Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation , 2014, Oncotarget.
[180] Lorraine Wilson,et al. Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes. , 2008, Lung cancer.
[181] Sazali Yaacob,et al. Advancements in Transmitters and Sensors for Biological Tissue Imaging in Magnetic Induction Tomography , 2012, Sensors.
[182] Yasar Gurbuz,et al. A novel magnetic particle-modified electrochemical sensor for immunosensor applications , 2012 .
[183] M Groth,et al. Intraindividual comparison of contrast-enhanced MRI and unenhanced SSFP sequences of stenotic and non-stenotic pulmonary artery diameters. , 2011, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[184] Wei He,et al. A multi-channel magnetic induction tomography measurement system for human brain model imaging. , 2009, Physiological measurement.
[185] Abhishek Mahajan,et al. ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country , 2016, PloS one.
[186] Oliver Sedlaczek,et al. Modern diagnostic and therapeutic interventional radiology in lung cancer. , 2013, Journal of thoracic disease.
[187] C. Caucheteur,et al. Cancer biomarker sensing using packaged plasmonic optical fiber gratings: Towards in vivo diagnosis. , 2017, Biosensors & bioelectronics.
[188] Francesca Pentimalli,et al. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery. , 2013, Mass spectrometry reviews.
[189] Ugo Pastorino,et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[190] 工藤 博幸. 低被曝CTにおける画像再構成法:―統計的画像再構成,逐次近似画像再構成,圧縮センシングの基礎― , 2014 .
[191] M. Komorowski,et al. A New Transducer for Magnetic Induction Tomography , 2009, IEEE Transactions on Magnetics.
[192] Somayeh Heydari,et al. Application of Nanoparticles in Quartz Crystal Microbalance Biosensors , 2014 .
[193] Hong Qiu,et al. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[194] Joachim Schneider,et al. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. , 2003, Anticancer research.
[195] Shulin Zhao,et al. Noncompetitive immunoassay for carcinoembryonic antigen in human serum by microchip electrophoresis for cancer diagnosis. , 2010, Clinica chimica acta; international journal of clinical chemistry.